Alnylam Pharmaceuticals, Inc.
REVERSIR TM COMPOUNDS

Last updated:

Abstract:

The present invention relates, in general to agents that modulate the pharmacological activity of conjugated siRNAs.

Status:
Application
Type:

Utility

Filling date:

10 Aug 2021

Issue date:

18 Aug 2022